The price of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) shares last traded on Wall Street fell -0.90% to $43.81.
CRBP stock price is now 3.93% away from the 50-day moving average and 104.48% away from the 200-day moving average. The market capitalization of the company currently stands at $468.33M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $60 to $80, Oppenheimer maintained Outperform rating for Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP). On May 13, 2024, RBC Capital Mkts recently initiated its ‘Outperform’ rating on the stock quoting a target price of $77, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Cohen Yuval, Chief Executive Officer sold 22,938 shares of the company’s stock on Jun 18 ’24. The stock was sold for $968,832 at an average price of $42.24. Upon completion of the transaction, the Chief Executive Officer now directly owns 77,221 shares in the company, valued at $3.38 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 18 ’24, Chief Financial Officer Moran Sean F. sold 1,958 shares of the business’s stock. A total of $82,479 was realized by selling the stock at an average price of $42.12. This leaves the insider owning 48,605 shares of the company worth $2.13 million. A total of 1.24% of the company’s stock is owned by insiders.
During the past 12 months, Corbus Pharmaceuticals Holdings Inc has had a low of $3.03 and a high of $55.41. As of last week, the company has a debt-to-equity ratio of 0.18, a current ratio of 4.69, and a quick ratio of 4.69. The fifty day moving average price for CRBP is $42.2246 and a two-hundred day moving average price translates $21.608 for the stock.
The latest earnings results from Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was released for 2024-03-31. The company reported revenue of $9.62 million for the quarter, compared to $17.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -44.37 percent.
